From Tariffs to Opportunity: How to Invest Strategically in a Shifting Global Trade Landscape

When navigating during uncertain or volatile market conditions, investment portfolios should prioritise caution and flexibility. Holding a healthy cash position is essential as the saying goes ‘cash is king’. Certainly, during frequently shifting market sentiment, facilitating readiness to act when genuine opportunities arise is crucial. For new investments, confirmation of trend reversals or stability before entering positions is a strategy to avoid catching falling knives.


For new investments, waiting for confirmation of trend reversals or market stability before entering positions is a prudent strategy to avoid catching falling knives. Implementing a dollar-cost averaging (DCA) approach enables positions to be built gradually, helping to mitigate the effects of market volatility and emotional decision-making. A balanced investment strategy assists in managing risk while positioning a portfolio to capitalise on potential rebounds.

Trump Tariff Policy Outlook


Analysing recent commentary from Trump and his administration regarding tariffs reveals complicated and potentially fluid policy direction. While official statements have maintained a firm stance on the newly imposed tariffs, tariffs are looking more like a negotiation tactic (specifically the U.S. President sharing TikTok videos that suggested that tariffs were part of an intentional negotiation tactic that will not actually go forward with full force). As countries begin negotiating with the U.S. to reduce these tariffs, particularly nations heavily reliant on exports to the U.S. who have strong incentives to push for tariff reductions, a short term rebound from last week’s market fall seems likely. However, it is a matter of when as it is uncertain how long the markets will continue to decline until this happens.


Speculatively, if Trump does roll back tariffs possibly in response to domestic pushback over rising consumer prices, there could be significant investment opportunities. Tech and other sectors that were previously hit hard by the tariffs may be poised for a sharp recovery, driven by renewed investor confidence and improved global trade sentiment. Capitalising on these sectors while they remain undervalued could offer high upside potential, especially in the early stages of a  reversal.


Shorting the market (early panic stage)


In the early stages of market panic, shorting the market can be a tactical move for investors anticipating further turbulence. Given the current climate of uncertainty fuelled by ongoing announcements from Trump’s administration, volatility is expected to remain elevated. One way to capitalise on this is through volatility-focused or inverse exchange-traded funds (ETFs). These instruments are designed to move in the opposite direction of market indices, offering downside exposure without directly shorting individual stocks. For example, SQQQ is an inverse ETF that provides 3x daily short leverage to the NASDAQ-100 Index, allowing investors to potentially profit from continued market declines. While powerful, these tools carry higher risk and are best used with strict risk management and short-term horizons.


Gradual Accumulation of Reliable Securities


During periods of heightened volatility and market downturns, a prudent strategy is to slowly accumulate high-quality securities as their prices dip. A focus on oversold blue-chip stocks with strong balance sheets and solid fundamentals, as these companies are more likely to weather economic shocks and rebound over time. Additionally, beaten-down sector leaders in industries such as big tech, industrials, and banking are areas of interest, as they often experience sharp recoveries once market sentiment improves. For long-term growth potential, thematic ETFs in areas like artificial intelligence, green energy, and cybersecurity can offer exposure to future-focused sectors currently trading at discounted levels. A disciplined, dollar-cost averaging approach can help manage risk while building long-term value.


Historical trends during financial crises and economic recession


Looking at former worldwide financial market crises like the global financial crisis (GFC) and COVID can inform effective strategies to navigate the current global trade crisis. By analysing a combination of factors from both events, parallels can be drawn to better understand how investors, markets, and governments are likely to respond to economic shocks. 


The GFC serves as a reference point for understanding typical investor behaviour and policy responses following a major financial collapse. It highlights patterns in how market confidence is gradually restored and capital is reallocated across sectors, as well as which industries tend to suffer most and which are more resilient during recovery.


In contrast, the COVID-19 crisis represented a different kind of disruption, stemming from widespread shutdowns, supply chain breakdowns, and sudden changes in consumer and business behaviour. This crisis highlighted the adaptability and resilience of sectors linked to technology and innovation. Notably, technology and growth stocks often heavily oversold during steep downturns, rebounded rapidly as investor sentiment recovered. For instance, the Nasdaq index surged after both the GFC and the COVID-19 crash, with tech stocks leading the recovery just months after the March 2020 bottom.


Today’s global trade crisis can be viewed as a policy-induced shock, driven by escalating tariffs and trade tensions, rather than systemic financial failure or a public health emergency. While the GFC was rooted in internal economic flaws and COVID-19 stemmed from external disruption, the current crisis involves deliberate changes to international trade frameworks with broad economic consequences. In this context, the COVID-19 recovery may offer a more relevant comparison, particularly in terms of supply chain challenges, inflationary pressures, and shifts in market dynamics.


Supply chain disruptions have been a common recurring theme across these crises. During COVID-19, lockdowns and restrictions led to significant bottlenecks, highlighting vulnerabilities in global supply networks. Similarly, the current trade tensions have exacerbated supply chain challenges, with tariffs increasing costs and prompting companies to reevaluate sourcing strategies. These disruptions underscore the importance for investors to consider companies with robust, adaptable supply chains and to be cautious of those heavily reliant on geopolitically sensitive regions.​

Subscribe to our newsletter

Disclaimer: This article does not constitute financial advice nor a recommendation to invest in the securities listed. The information presented is intended to be of a factual nature only. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing.

Is a Share Advisor

right for you?

May 8, 2026
Learn how professional investors analyse earnings reports by assessing revenue quality, margins, cash flow, balance sheet strength and management guidance.
By Debie Deslate May 7, 2026
Global energy risks are rising. Australia just committed $10.7 billion to respond. A closer look at the economic risks driving Australia’s push for greater fuel security.
May 6, 2026
The RBA has lifted rates to 4.35%. Here’s what it means for households, inflation, markets, sector performance and the outlook for Australian investors.
May 6, 2026
About The a2 Milk Co Ltd The a2 Milk Company Limited, together with its subsidiaries, sells A2-type protein type branded milk and related products in Australia, New Zealand, China, rest of Asia, and the United States. The company offers infant milk formula; other nutritional products and milk; manufactures and sells nutritional and ingredients products, as well as provides rent, royalty, and licensing services. It offers its products under the a2 Milk and a2 Platinum brands. The company was formerly known as A2 Corporation Limited and changed its name to The a2 Milk Company Limited in April 2014. The a2 Milk Company Limited was incorporated in 2000 and is based in Auckland, New Zealand. Source: EODHD Key Stats
May 5, 2026
About Meta Platforms Inc Meta Platforms, Inc. engages in the development of products that enable people to connect and share with friends and family through mobile devices, personal computers, virtual reality (VR) headsets, and AI glasses in the United States, Canada, Europe, Asia-Pacific, and internationally. It operates through two segments, Family of Apps (FoA) and Reality Labs (RL). The FoA segment offers Facebook, which enables people to build community through feed, reels, stories, groups, marketplace, and other; Instagram that brings people closer through Instagram feed, stories, reels, live, and messaging; Messenger, a messaging application for people to connect with friends, family, communities, and businesses across platforms and devices through text, audio, and video calls; Meta AI, an assistant that's available across apps, as a stand-alone app, on AI glasses, and on the web; Threads, an application for text-based updates and public conversations; and WhatsApp, a messaging application that is used by people and businesses to communicate and transact in a private way. The RL segment provides virtual and augmented reality products, including consumer hardware, software, and content that help people feel connected anytime and anywhere, as well as Meta Quest devices that enable social experiences across gaming, fitness, entertainment, and more. The segment also includes wearables such as AI glasses like Ray Ban Meta and Oakley Meta glasses, featuring Meta AI for advanced conversational and hands free interaction; and the Meta Ray Ban Display, which combines AI glasses with an integrated lens display and the Meta Neural Band, a wrist worn device using electromyography that lets people control their AI glasses through neuromuscular signals. The company was formerly known as Facebook, Inc. and changed its name to Meta Platforms, Inc. in October 2021. The company was incorporated in 2004 and is headquartered in Menlo Park, California. Source:EODHD Key Stats
May 5, 2026
About Amazon.com Inc Amazon.com, Inc. engages in the retail sale of consumer products, advertising, and subscriptions service through online and physical stores in North America and internationally. The company operates through three segments: North America, International, and Amazon Web Services (AWS). It also manufactures and sells electronic devices, including Kindle, fire tablets, fire TVs, echo, ring, blink, and eero; and develops and produces media content. In addition, the company offers programs that enable sellers to sell their products in its stores; and programs that allow authors, independent publishers, musicians, filmmakers, Twitch streamers, skill and app developers, and others to publish and sell content. Further, it provides compute, storage, Artificial intelligence, database, analytics, machine learning, and other services, as well as advertising services through programs, such as sponsored ads, display, and video advertising. Additionally, the company offers Amazon Prime, a membership program. The company's products offered through its stores include merchandise and content purchased for resale and products offered by third-party sellers. It serves consumers, sellers, developers, enterprises, content creators, advertisers, and employees. The company was incorporated in 1994 and is headquartered in Seattle, Washington. Source:EODHD Key Stats
May 1, 2026
Earnings may beat expectations, but guidance drives markets. Learn how to read forward outlooks, tone and signals to better interpret stock price reactions.
May 1, 2026
About Visa Inc. Visa Inc. operates as a payment technology company in the United States and internationally. The company operates VisaNet, a transaction processing network that enables authorization, clearing, and settlement of payment transactions. It also offers credit, debit, and prepaid card products; tap to pay, tokenization, and click to pay services; Visa Direct, a solution that facilitates the delivery of funds to eligible cards, bank accounts, and digital wallets; Visa B2B Connect, a multilateral business-to-business cross-border payments network; Visa Cross-Border Solution, a cross-border consumer payments solution; and Visa DPS that provides a range of value-added services, including fraud mitigation, dispute management, data analytics, campaign management, a suite of digital solutions, and contact center services. The company also provides acceptance solutions, which include Cybersource and Authorize.net that provides new and enhanced payment integrations with ecommerce platforms, enabling sellers and acquirers to offer tailored commerce experiences; risk and identity solutions, such as Visa Advanced Authorization, Visa Secure, Visa Consumer Authentication Service, Visa Protect Authentication Intelligence, and Visa Provisioning Intelligence; and Visa Consulting and Analytics, a payment consulting advisory services. It provides its services under the Visa, Visa Electron, Interlink, V PAY, and PLUS brands. The company serves merchants, financial institutions, and government entities. Visa Inc. was founded in 1958 and is headquartered in San Francisco, California. Source:EODHD Key Stats
May 1, 2026
About Telix Pharmaceuticals Ltd Telix Pharmaceuticals Limited, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals. The company operates through three segments: Precision Medicine, Therapeutics, and Manufacturing Solutions. Its lead therapeutic product candidate is TLX591, a lutetium-labeled radio antibody-drug conjugate (rADC), which is in a Phase 3 clinical trial in patients with advanced prostate cancer. The company develops TLX250, an rADC for treating advanced metastatic kidney cancer; TLX101, a systemic therapy for the treatment of glioblastoma; TLX66, a product candidate for bone marrow conditioning for hematopoietic stem cell transplant conditioning; and Illuccix and Gozellix for the treatment of prostate cancer. The company is also developing TLX592, a prostate cancer therapy candidate for targeted alpha therapy based on its proprietary RADmAb-engineered antibody technology; TLX252 for the treatment of patients with advanced metastatic kidney cancer; TLX400, a bladder fibroblast activation protein for treating various tumors; TLX102, a large amino acid transporter-targeting small molecule-based alpha therapy candidate for the treatment of glioblastoma and multiple myeloma; TLX300 for treating soft tissue sarcoma; and TLX090, a bone-seeking agent for bone metastases and pain palliation. In addition, it is developing BiPASS, which is in Phase 3 clinical trial for prostate cancer diagnosis; AlFluor, a novel PET radiochemistry solution; TLX250-Px, a PET diagnostic imaging agent; and TLX101-Px, a radiolabeled amino acid PET agent. It operates in Australia, Belgium, Canada, the United Kingdom, the United States, and internationally. The company has strategic collaboration with University Hospital Essen. The company was founded in 2015 and is headquartered in North Melbourne, Australia. Source:EODHD Key Stats
April 30, 2026
The UAE leaves OPEC on 1 May. Oil prices did not move. Here is why the near-term calm is masking a structural shift investors should not ignore.